XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net Sales $ 18,691 $ 15,988 $ 53,497 $ 46,599
Cost of Sales 17,914 16,317 51,760 46,788
Gross Profit (Loss) 777 (329) 1,737 (189)
Research and Product Development 469 1,221 2,963 5,445
Selling and Marketing 762 1,541 1,743 4,860
General and Administrative 3,254 3,881 11,845 11,483
Operating Loss (3,708) (6,972) (14,814) (21,977)
Other (Expense) Income        
Realized Gain on Investments 0 0 4 (1)
Interest Expense (476) (609) (1,497) (1,772)
Interest Income (6) 0 (10) 17
Total Other Expense (482) (609) (1,503) (1,756)
Net Loss $ (4,190) $ (7,581) $ (16,317) $ (23,733)
Basic Net Loss per Share (in dollars per share) $ (0.40) $ (0.89) $ (1.75) $ (2.79)
Diluted Net Loss per Share (in dollars per share) $ (0.40) $ (0.89) $ (1.75) $ (2.79)
Basic Weighted Average Shares Outstanding (in shares) 10,528,148 8,534,740 9,299,788 8,520,603
Diluted Weighted Average Shares Outstanding (in shares) 10,528,148 8,534,740 9,299,788 8,520,603